1.Effects of propyl gallate on adhesion of polymorphonuclear leukocytes to human endothelial cells induced by tumor necrosis factor alpha.
Yue-Rong JIANG ; Ke-Ji CHEN ; Yong-Gang XU ; Xiao-Hong YANG ; Hui-Jun YIN
Chinese journal of integrative medicine 2009;15(1):47-53
OBJECTIVETo investigate the effects of Propyl Gallate (PrG) on cellular adhesion between human To investigate the effects of Propyl Gallate (PrG) on cellular adhesion between human umbilical vein endothelial cells (HUVEC) and polymorphonuclear leukocytes (PMN) as well as the expression umbilical vein endothelial cells (HUVEC) and polymorphonuclear leukocytes (PMN) as well as the expression of intercellular adhesion molecule-1 (ICAM-1, CD54) and E-selectin (CD62E) on the VEC surface. of intercellular adhesion molecule-1 (ICAM-1, CD54) and E-selectin (CD62E) on the VEC surface.
METHODSA human VEC inflammation model was induced by tumor necrosis factor alpha (TNF-alpha). VECs were pre- A human VEC inflammation model was induced by tumor necrosis factor alpha (TNF-alpha). VECs were preincubated with varying concentrations of PrG (0.001-5 mmol/L) or 1 per thousand DMSO (v:v) or 10 mmol/L acetylsalicylic incubated with varying concentrations of PrG (0.001-5 mmol/L) or 1 per thousand DMSO (v:v) or 10 mmol/L acetylsalicylic acid (ASA) for 1 h, and then were stimulated with 10 ng/mL TNF-alpha for 6 h. Rose bengal vital staining method acid (ASA) for 1 h, and then were stimulated with 10 ng/mL TNF-alpha for 6 h. Rose bengal vital staining method was used to measure the adherence rate of PMN to VEC, while flow cytometry was used to determine the was used to measure the adherence rate of PMN to VEC, while flow cytometry was used to determine the expression of CD54 and CD62E on the VEC surface. expression of CD54 and CD62E on the VEC surface.
RESULTSAfter 6 h of incubation with TNF-alpha, the adherence After 6 h of incubation with TNF-alpha, the adherence of PMN to HUVECs as well as the percentage of fluorescence-positive cells and mean fluorescence intensity of PMN to HUVECs as well as the percentage of fluorescence-positive cells and mean fluorescence intensity (MFI) of surface CD54 and CD62E in HUVECs increased significantly ( (MFI) of surface CD54 and CD62E in HUVECs increased significantly (P<0.01). Pre-treatment of HUVECs with <0.01). Pre-treatment of HUVECs with PrG (0.1-5 mmol/L) significantly suppressed the adherence of PMN to VECs induced by TNF-alpha (PrG (0.1-5 mmol/L) significantly suppressed the adherence of PMN to VECs induced by TNF-alpha (P<0.05). PrG <0.05). PrG (1-5 mmol/L) inhibited the VEC surface expression of CD62E and CD54 in a dose-dependent way ( (1-5 mmol/L) inhibited the VEC surface expression of CD62E and CD54 in a dose-dependent way (P<0.05). PrG <0.05). PrG at lower concentrations (0.001-0.1 mmol/L) showed no effect on CD54 expression, while it showed a slightly at lower concentrations (0.001-0.1 mmol/L) showed no effect on CD54 expression, while it showed a slightly increasing trend in CD62E expression (increasing trend in CD62E expression (P>0.05). ASA at 10 mmol/L had no obvious effect on the positive rate of >0.05). ASA at 10 mmol/L had no obvious effect on the positive rate of CD62E and CD54. CD62E and CD54.
CONCLUSIONSHigh concentrations of PrG (0.1-5 mmol/L) exert its inhibitory effect on cellular High concentrations of PrG (0.1-5 mmol/L) exert its inhibitory effect on cellular adherence of PMN to HUVECs, and its mechanism may be related to inhibiting surface expression of CD54 and adherence of PMN to HUVECs, and its mechanism may be related to inhibiting surface expression of CD54 and CD62E in HUVECs. Its action concentration was lower than that of ASA. CD62E in HUVECs. Its action concentration was lower than that of ASA.
Cell Adhesion ; drug effects ; Endothelial Cells ; cytology ; drug effects ; Flow Cytometry ; Fluorescein-5-isothiocyanate ; metabolism ; Fluorescence ; Humans ; Intercellular Adhesion Molecule-1 ; metabolism ; Neutrophils ; cytology ; drug effects ; Propyl Gallate ; chemistry ; pharmacology ; Staining and Labeling ; Tumor Necrosis Factor-alpha ; pharmacology
2.Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay.
Han FU ; Guan-Lian HU ; Qin HE
Acta Pharmaceutica Sinica 2014;49(7):1054-1061
The preparation method, serum stability, efficiency of cellular uptake and apoptosis induction of the cell penetrating peptide TAT and cleavable PEG co-modified liposomes loaded with paclitaxel (C-TAT-Lipo) were investigated. The best preparation procedure was performed by orthogonal test based on single factor screening method. First, the paclitaxel (PTX)-loaded liposomes were prepared by filming-rehydration method, evaluated with entrapment efficiency and polydispersity index. The morphology of C-TAT-Lipo was characterized by transmission electron microscopy. Turbidity variations were monitored in the presence of fetal bovine serum (FBS) to evaluate the serum stability of the liposomes developed here. Next, the efficiency of cellular uptake of different Rho-PE-labeled liposomes on B16F1 cells in vitro was evaluated by confocal laser scanning microscopy (CLSM) and flow cytometry. The quantitative analysis of apoptosis induced by different PTX-loaded liposomes was performed by Annexin V-FITC/PI double staining. The optimal formulation was as follows: Chol : lipid: 1 : 8 (molar ratio); drug : lipid: 1 : 40 (mass ratio); lipid concentration: 3 mmol x L(-1); temperature of hydration: 25 degrees C. The mean size and polydispersity index of C-TAT-Lipo were about (97.97 +/- 3.68) nm and 0.196 +/- 0.037, the zeta potential was (-0.89 +/- 0.45) mV, the entrapment efficiency of paclitaxel was (90.16 +/- 1.53)%. The particle sizes did not exhibit significant variations in 50% FBS over 24 h at 37 degrees C. The efficiency of cellular uptake of the C-TAT-Lipo increased 1.40 fold following the cleavage of PEG. Apoptosis analysis showed 59.3% increase of the apoptosis and necrosis profile of C-TAT-Lipo after the detachment of PEG shells, which was markedly higher than that of N-TAT-LP with or without glutathione and SL, respectively. The results indicate that the C-TAT-Lipo is successfully prepared by filming-rehydration method and shows significant antitumor activities.
Animals
;
Annexin A5
;
Apoptosis
;
Cell Line, Tumor
;
Cell-Penetrating Peptides
;
pharmacology
;
Fluorescein-5-isothiocyanate
;
analogs & derivatives
;
Liposomes
;
chemistry
;
Melanoma, Experimental
;
Mice
;
Microscopy, Confocal
;
Paclitaxel
;
pharmacology
;
Particle Size
;
Polyethylene Glycols
;
chemistry
3.Folate Receptor Targeted Imaging Using Poly (ethylene glycol)-folate: In Vitro and In Vivo Studies.
Se Lim KIM ; Hwan Jeong JEONG ; Eun Mi KIM ; Chang Moon LEE ; Tae Hyoung KWON ; Myung Hee SOHN
Journal of Korean Medical Science 2007;22(3):405-411
The aim of this study was to ascertain the folate receptor (FR) targetability by an in vitro study and to acquire FR-targeted images in vivo models by using synthetic folate conjugates. PEG-folate was synthesized and labeled with (99m)Tc and fluorescein isothiocynate (FITC). Cell uptake studies were carried out in KB cells (FR-positive) and A549 cells (FR-negative) using FITC- and the (99m)Tc-labeled conjugates. The radiolabeled conjugate was intravenously injected to KB tumor xenografted mice. After it was injected, gamma images were recorded at 30 min, 1, 2, 3 and 4 hr. Cell uptake studies showed a difference between the KB cells and the A549 cells by flow cytometry analysis and gamma counting. On in vivo images, the tumor-tonormal muscle ratio was greater than 4. It ascertained that the PEG-folate conjugate specifically binds to the FR expressed on tumor cells in vitro. Moreover, it was possible to acquire the FR-targeted gamma images using PEG-folate conjugates in tumor models.
Animals
;
Carrier Proteins/*metabolism
;
Cell Line, Tumor
;
Female
;
Fluorescein-5-isothiocyanate/pharmacology
;
Folic Acid/*metabolism
;
Humans
;
Image Processing, Computer-Assisted
;
Mice
;
Mice, Nude
;
Microscopy, Fluorescence
;
Neoplasm Transplantation
;
Polyethylene Glycols/*chemistry
;
Receptors, Cell Surface/*metabolism
;
Technetium/*chemistry
;
Time Factors
4.Effects of endothelial microvesicles induced by A23187 on H9c2 cardiomyocytes.
Man SHANG ; Qi ZHANG ; Meng-Xiao ZHANG ; Yao WANG ; Yan CHEN ; Yan-Na WU ; Jun-Qiu SONG ; Ming-Lin LIU ; Yan-Xia LIU
Chinese Journal of Applied Physiology 2013;29(6):559-564
OBJECTIVETo investigate the effects of endothelial microvesicles (EMVs) induced by calcium ionophore A23187 on H9c2 cardiomyocytes.
METHODSHuman umbilical vein endothelial cells (HUVECs) were treated with 10 micromol/L A23187 for 30 min. EMVs from HUVECs were isolated by ultracentrifugation from the conditioned culture medium. EMVs were characterized using 1 and 2 microm latex beads and anti-PE-CD144 antibody by flow cytometry. For functional research, EMVs at different concentrations were cocultured with H9c2 cardiomyocytes for 6 h. Cell viability of H9c2 cells and the activity of LDH leaked from H9c2 cells were tested by colorimetry. Moreover, apoptosis of H9c2 cells was observed through Hoechst 33258 staining and tested by FITC-Annexin V/PI double staining.
RESULTSEMVs were induced by A23187 on HUVECs, and isolated by ultracentrifugation. We identified the membrane vesicles (< 1 microm) induced by A23187 were CD144 positive. In addition, the EMVs could significantly reduce the viability of H9c2 cells, and increase LDH leakage from H9c2 cells in a dose dependent manner (P < 0.05). Condensed nuclei could be observed with the increasing concentrations of EMVs through Hoechst 33258 staining. Furthermore, increased apoptosis rates of H9c2 cells could be assessed through FITC-Annexin V/PI double staining by flow cytometry.
CONCLUSIONMicrovesicles could be released from HUVECs after induced by A23187 through calcium influx, and these EMVs exerted a pro-apoptotic effect on H9c2 cells by induction of apoptosis.
Annexin A5 ; Apoptosis ; Calcimycin ; pharmacology ; Calcium ; metabolism ; Cell Line ; Cell Membrane ; drug effects ; Coculture Techniques ; Flow Cytometry ; Fluorescein-5-isothiocyanate ; analogs & derivatives ; Human Umbilical Vein Endothelial Cells ; Humans ; Myocytes, Cardiac ; drug effects ; Staining and Labeling
5.Effects of lipopolysaccharide on actin reorganization and actin pools in endothelial cells.
Qiao-bing HUANG ; Li SONG ; Ke-sen ZHAO ; Bo CHEN ; Xu-liang HUANG
Chinese Journal of Traumatology 2004;7(4):195-200
OBJECTIVETo investigate the dose and time-dependent effects of lipopolysaccharide (LPS) on cytoskeletal F-acitn and G-actin reorganizations by visualizing their distribution and measuring their contents in human umbilical vein endothelial cell line ECV-304.
METHODSF-actin was labeled with rhodamine-phalloidin and G-actin with deoxyribonuclease I (DNase I)conjugated with fluorescein isothiocyanate (FITC). Contents of cytoskeletal proteins were obtained by flow cytometry.
RESULTSF-actin was mainly distributed peripherally in endothelial cells under normal conditions. LPS stimulation caused the formation of stress fibers and filopodia. G-actin was normally seen in perinuclear and nuclear areas in control ECV-304 cells. Under LPS stimulation, G-actin dots appeared in the cytoplasmic region. The actin disorganization was accompanied by the time- and dose- dependent decrease in F-actin pool and increase in G-actin pool.
CONCLUSIONSLPS can induce characteristic morphological alterations of actin cytoskeleton and formation of intercellular gap in endothelial cells, accompanied by changes in F-actin and G-actin pools.
Actins ; drug effects ; Analysis of Variance ; Cells, Cultured ; Deoxyribonuclease I ; Dose-Response Relationship, Drug ; Endothelial Cells ; chemistry ; Escherichia coli ; Fluorescein-5-isothiocyanate ; Fluorescent Dyes ; Humans ; Lipopolysaccharides ; pharmacology ; Phalloidine ; Rhodamines ; Umbilical Veins ; cytology
6.Effects of Rho/ROCK signal pathway on AGEs-induced morphological and functional changes in human dermal microvascular endothelial cells..
Ji-Ping WANG ; Xiao-Hua GUO ; Ling-Jun WANG ; Qiang LI ; Bo CHEN ; Wei WU ; Xu-Liang HUANG ; Qiao-Bing HUANG
Acta Physiologica Sinica 2009;61(2):132-138
The present study aimed to determine the role of Rho/Rho kinase (Rho/ROCK) phosphorylation on advanced glycation end products (AGEs)-induced morphological and functional changes in human dermal microvascular endothelial cells (HMVECs). HMVECs were respectively incubated with different concentrations of AGEs-modified human serum albumin (AGEs-HSA) for different time. In some other cases, HMVECs were pretreated with ROCK inhibitors (H-1152 or Y-27632). The morphological changes of F-actin cytoskeleton were visualized by rhodamine-phalloidin staining and the phosphorylation of Rho and ROCK were determined by Western blot. Endothelial monolayer permeability was assessed by measuring the flux of FITC-albumin across the endothelial cells. The results showed that the distribution of F-actin was significantly altered by AGEs-HSA in time and dose-dependent patterns. These effects were inhibited by ROCK inhibitors. The phosphorylation of Rho and RCOK was remarkably increased by AGEs-HSA treatment while total Rho and ROCK protein levels were not affected. The permeability of endothelial monolayer was dramatically increased by AGEs-HSA, and both ROCK inhibitors (H-1152 or Y-27632) attenuated these hyperpermeability responses. The results obtained suggest that the phosphorylation of Rho/ROCK plays an important role in AGEs-induced morphological and functional alterations in HMVECs.
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
;
analogs & derivatives
;
pharmacology
;
Actin Cytoskeleton
;
metabolism
;
Actins
;
metabolism
;
Amides
;
pharmacology
;
Endothelial Cells
;
metabolism
;
Endothelium, Vascular
;
cytology
;
Fluorescein-5-isothiocyanate
;
analogs & derivatives
;
metabolism
;
Glycation End Products, Advanced
;
pharmacology
;
Humans
;
Phalloidine
;
analogs & derivatives
;
Phosphorylation
;
Pyridines
;
pharmacology
;
Rhodamines
;
Serum Albumin
;
metabolism
;
pharmacology
;
Serum Albumin, Human
;
Signal Transduction
;
rho-Associated Kinases
;
metabolism
7.Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway.
Xiao-Dan LIU ; Cheng-Yang SONG ; Cui-Cui KONG ; Xin TIAN
Chinese journal of integrative medicine 2022;28(10):900-908
OBJECTIVE:
To explore the effect and mechanism of action of bufalin in triple-negative breast cancer (TNBC) drug-resistant cell lines.
METHODS:
The normal human mammary epithelial cell line, TNBC cell line, TNBC adriamycin-resistant cell line, and TNBC docetaxel-resistant cell line were treated with different doses of bufalin (0-1,000 nmol/L) at different time points (0-72 h). Propidium iodide staining, AV-FITC/PI double staining, Hoechst 33342/PI double staining and transmission electron microscopy (TEM) were used to evaluate the death patterns of the cell lines.
RESULTS:
Bufalin killed the TNBC cell line and its drug-resistant cell lines in a dose/time-dependent manner (all P<0.01). After treatment with bufalin for 24 h, the adriamycin-resistant cell line showed a co-existing pattern of necroptosis and apoptosis. However, at 48 h, necroptosis was the main manifestation. After treatment with bufalin, the expressions of tumor necrosis factor α, phospho-tumor necrosis factor receptor 1, phospho-receptor interacting protein 1 and c-caspase 3 increased (all P<0.01), the killing effect of bufalin could be mostly inhibited by NEC-1, and by z-VAD-fmk (both P<0.01). Besides, the intracellular reactive oxygen species (ROS) levels increased considerably (P<0.01), the antioxidant N-acetyl cysteine or Nec-1 could inhibit the increase of ROS level and the killing effect of bufalin (all P<0.01). The adriamycin-resistant cell line exhibited necroptosis characteristic after 48 h of bufalin treatment under TEM.
CONCLUSIONS
Bufalin could induce necroptosis through RIP1/ROS-mediated pathway to kill the drug-resistant TNBC cell lines. This finding provides critical experimental data and theoretical basis for the clinical application of bufalin to overcome the difficulties in the treatment of TNBC.
Antioxidants/pharmacology*
;
Apoptosis
;
Bufanolides
;
Caspase 3/metabolism*
;
Cell Line
;
Cell Line, Tumor
;
Cysteine/pharmacology*
;
Docetaxel/pharmacology*
;
Doxorubicin/pharmacology*
;
Fluorescein-5-isothiocyanate/pharmacology*
;
Humans
;
Necroptosis
;
Propidium/pharmacology*
;
Reactive Oxygen Species/metabolism*
;
Receptors, Tumor Necrosis Factor
;
Triple Negative Breast Neoplasms/drug therapy*
;
Tumor Necrosis Factor-alpha/pharmacology*
8.Chlorogenic Acid Decreases Retinal Vascular Hyperpermeability in Diabetic Rat Model.
Joo Young SHIN ; Joonhong SOHN ; Kyu Hyung PARK
Journal of Korean Medical Science 2013;28(4):608-613
To evaluate the effect of chlorogenic acid (CGA), a polyphenol abundant in coffee, on retinal vascular leakage in the rat model of diabetic retinopathy, Sprague-Dawley rats were divided into four groups: controls, streptozotocin-induced diabetic rats, and diabetic rats treated with 10 and 20 mg/kg chlorogenic acid intraperitoneally daily for 14 days, respectively. Blood-retinal barrier (BRB) breakdown was evaluated using FITC-dextran. Vascular endothelial growth factor (VEGF) distribution and expression level was evaluated with immunohistochemistry and Western blot analysis. Expression of tight junction proteins, occludin and claudin-5, and zonula occludens protein, ZO-1 was also evaluated with immunohistochemistry and Western blot analysis. BRB breakdown and increased vascular leakage was found in diabetic rats, with increased VEGF expression and down-regulation of occludin, claudin-5, and ZO-1. CGA treatment effectively preserved the expression of occludin, and decreased VEGF levels, leading to less BRB breakdown and less vascular leakage. CGA may have a preventive role in BRB breakdown in diabetic retinopathy by preserving tight junction protein levels and low VEGF levels.
Animals
;
Blood-Retinal Barrier/*drug effects
;
Chlorogenic Acid/metabolism/*pharmacology
;
Claudin-5/metabolism
;
Dextrans/chemistry
;
Diabetes Mellitus, Experimental/complications/metabolism/*pathology
;
Diabetic Retinopathy/etiology/prevention & control
;
Down-Regulation
;
Fluorescein-5-isothiocyanate/chemistry
;
Male
;
Occludin/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Retina/*metabolism
;
Tight Junction Proteins/metabolism
;
Vascular Endothelial Growth Factor A/metabolism
;
Zonula Occludens-1 Protein/metabolism
9.Prevention of chronic graft-versus-host disease by stimulation with glucocorticoid-induced TNF receptor.
Juyang KIM ; Woon Sun CHOI ; Hye Jeong KIM ; Byungsuk KWON
Experimental & Molecular Medicine 2006;38(1):94-99
GITR (glucocorticoid-induced TNF receptor) is a recently identified member of the TNF receptor superfamily. The receptor is preferentially expressed on CD4+CD25+ regulatory T cells and GITR signals break the suppressive activity of the subset. In this study, we wanted to reveal the in vivo function of GITR in chronic graft-versus-host disease (cGVHD), a lupus-like autoimmune disease. A single injection of anti-GITR monoclonal antibody (DTA-1) was effective in blocking the progression of cGVHD in the parent-into-F1 model. Treatment of DTA-1 significantly decreased levels of IgG1 anti-DNA autoantibody, inhibited glomerulonephritis, and increased survival. The DTA-1-mediated inhibition of autoantibody production correlated with deletion of B cells and could occur independently of CD4+CD25+ regulatory T cells. Our results indicate that anti-GITR monoclonal antibody may be used as a potential immunotherapeutic agent for preventing cGVHD.
Animals
;
Antibodies, Monoclonal/therapeutic use
;
B-Lymphocytes/immunology
;
CD4-Positive T-Lymphocytes/drug effects/immunology/transplantation
;
Comparative Study
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Flow Cytometry
;
Fluorescein-5-isothiocyanate
;
Fluorescent Antibody Technique, Indirect
;
Fluorescent Dyes
;
Glucocorticoids/*pharmacology
;
Graft vs Host Disease/*prevention & control
;
Mice
;
Mice, Inbred DBA
;
Mice, Inbred Strains
;
Microscopy, Confocal
;
Receptors, Tumor Necrosis Factor/*immunology
;
Research Support, Non-U.S. Gov't
;
Transplantation, Homologous
10.Secretin induces neurite outgrowth of PC12 through cAMP-mitogen-activated protein kinase pathway.
Hyeon Soo KIM ; Sanatombi YUMKHAM ; Sun Hee KIM ; Kyungmoo YEA ; You Chan SHIN ; Sung Ho RYU ; Pann Ghill SUH
Experimental & Molecular Medicine 2006;38(1):85-93
The gastrointestinal functions of secretin have been fairly well established. However, its function and mode of action within the nervous system remain largely unclear. To gain insight into this area, we have attempted to determine the effects of secretin on neuronal differentiation. Here, we report that secretin induces the generation of neurite outgrowth in pheochromocytoma PC12 cells. The expressions of Tau and beta-tubulin, neuronal differentiation markers, are increased upon secretin stimulation. In addition, secretin induces sustained mitogen-activated protein kinase (MAPK) activation and also stimulates the cAMP secretion. Moreover, the neurite outgrowth elicited by secretin is suppressed to a marked degree in the presence of either PD98059, a specific MAPK/ERK kinase (MEK) inhibitor, or H89, a specific protein kinase A (PKA) inhibitor. Taken together, these observations demonstrate that secretin induces neurite outgrowth of PC12 cells through cAMP-MAPK pathway, and provide a novel insight into the manner in which secretin participates in neuritogenesis.
Animals
;
Cell Culture Techniques
;
Cell Differentiation/drug effects
;
Comparative Study
;
Cyclic AMP/analysis/metabolism
;
Enzyme-Linked Immunosorbent Assay
;
Fluorescein-5-isothiocyanate
;
Fluorescent Dyes
;
Immunoblotting
;
Immunohistochemistry
;
Microscopy, Confocal
;
Mitogen-Activated Protein Kinases/*metabolism
;
Neurites/*drug effects
;
Neurons/cytology/drug effects
;
PC12 Cells
;
Rats
;
Research Support, Non-U.S. Gov't
;
Reverse Transcriptase Polymerase Chain Reaction
;
Secretin/*pharmacology